France · Biotechnology startup
France · GenSight Biologics
GenSight Biologics develops gene therapy-based treatments for retinal degenerative diseases.
Funding reportedLast round: Post ipo equity
What company datasets say GenSight Biologics raised
Funding, as reported
Reported in all263.9Min the source's currency
Rounds14
Last roundPost ipo equity
Last round dateMay 2024
Investors listed19
Founders and team
From GenSight Biologics's own website: 15 on the team.
- Laurence RodriguezChief Executive Officer
- Julio BenedictoSenior Vice President, Strategy and Operations
- Sabrina ChekrounSenior Vice President, Regulatory Affairs and Quality
- Fang LiChief Regulatory & Quality Officer
- Jan Eryk UmiastowskiChief Financial Officer
- Magali TaielChief Medical Officer
- Scott JeffersChief Technical Officer
- Elsy BoglioliIndependent Director
- Françoise de CraeckerIndependent Director
- Maritza McIntyreIndependent Director
- Michael WyzgaChairman
- Prof. Botond RoskaChairman
- Prof. Jose-Alain SahelDirector
- Simone SeiterIndependent Director
- William MonteithIndependent Director
Biotechnology in France
Startups like it
Is this your company?
Add your raise, your deck and your story, and put GenSight Biologics in front of investors. Or tell us what we have wrong.